Clinical Trial Update: Procalcitonin as a Marker of Infection in Cancer Patients

View source ↗

Summary

A clinical trial update explores procalcitonin as a biomarker for infection in cancer patients. The current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Infection

Snippet

Sponsor: Herlev Hospital | Conditions: Infections, Cancer | Status: UNKNOWN